Biobank automation systems market seen reaching $3.19 billion by 2030

The biobank automation systems market is projected to grow from $2.03 billion in 2025 to $3.19 billion by 2030, driven by precision medicine, AI-enabled sample management and rising chronic disease demand. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Biobank automation is becoming central to sample handling as biomedical research, genomics and precision medicine expand. - Rising chronic disease rates are increasing demand for reliable biospecimen storage, faster retrieval and lower error rates. - The market’s growth points to broader adoption of robotics, software and AI in laboratory workflows.

What happened: - The Biobank Automation Systems market is expected to rise from $2.03 billion in 2025 to $2.22 billion in 2026. - The market is projected to reach $3.19 billion by 2030. - The forecast implies a 9.7% CAGR from 2025 to 2026 and a 9.4% CAGR through 2030. - North America held the largest regional share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Biobank automation systems use robotics and digital tools to collect, process, track, store and retrieve biological samples. - The systems are designed to improve accuracy, speed and security while reducing manual work and errors. - Integrated software, automated storage and high-throughput workflows support traceability and large-scale biorepository management. - Growth during the recent period was driven by biomedical research, rising biobank sample volumes, error reduction needs, genomics studies and laboratory automation adoption. - Future growth is expected to come from precision medicine, AI-driven sample management, global biobank collaborations, stricter regulatory compliance and demand for scalable storage. - Expected technology trends include automated sample storage, robotic sample handling, high-throughput biobanking, digital sample traceability and integrated biobank management software. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report highlights new 2026 features including market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, key technologies and future trends, and updated graphics and tables. - A free sample report is available here. - The full report is available here.

Between the lines: - The forecast suggests biobanking is shifting from a storage function to a data-driven, automation-heavy research infrastructure. - The rise of AI-driven sample management and regulatory pressure suggests buyers are prioritizing scale, traceability and compliance. - North America’s lead and Asia-Pacific’s faster growth indicate mature demand in one region and rapid infrastructure buildout in another.

What's next: - Biobank operators and lab technology vendors are likely to focus on automation, software integration and scalable storage systems. - Further adoption should track growth in oncology, genomics and other research areas that depend on large biospecimen inventories. - The Asia-Pacific market is positioned to narrow the gap as healthcare investment and biomedical research spending rise.

The bottom line: - Biobank automation systems are moving from niche lab tools to essential infrastructure for modern biomedical research and precision medicine.